Search research articles
Contact Us
Filters
Showing results (351-360 of 469) with videos related to
Page
of 47
Sort By:
Oncoimmunology
|
September 22, 2017
Colony-stimulating factor-1-induced AIF1 expression in tumor-associated macrophages enhances the progression of hepatocellular carcinoma
Hao Cai, Xiao-Dong Zhu, Jian-Yang Ao, et al.
Cell Death & Disease
|
May 1, 2018
The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target
Cheng-Dong Qin, De-Ning Ma, Shi-Zhe Zhang, et al.
Journal of Cancer Research and Clinical Oncology
|
May 22, 2010
Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expression
Yu-Quan Xiong, Hui-Chuan Sun, Xiao-Dong Zhu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 3, 2020
TRPC1/4/5 channels contribute to morphine-induced analgesic tolerance and hyperalgesia by enhancing spinal synaptic potentiation and structural plasticity
Wen-Guang Chu, Fu-Dong Wang, Zhi-Chuan Sun, et al.
Neural Regeneration Research
|
August 12, 2021
Downregulation of miR-491-5p promotes neovascularization after traumatic brain injury
Wei Tang, Zong-Duo Guo, Wei-Na Chai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
July 15, 2022
Hazard rate for postoperative recurrence in patients with hepatocellular carcinoma at Barcelona Clinic Liver Cancer stage 0 or A1: A multicenter observational study
Yan-Jun Xiang, Kang Wang, Hong-Ming Yu, et al.
Biomarker Research
|
January 13, 2025
The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapy
Tian He, Bin Xu, Lu-Na Wang, et al.
Cancer
|
September 2, 2006
P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma
Yong-Bing Qian, Ju-Bo Zhang, Wei-Zhong Wu, et al.
Clinical Chemistry
|
September 20, 2008
Abnormal matrix remodeling in adolescents and young adults with Kawasaki disease late after onset
Ming-Tai Lin, Shyh-Jye Chen, Yi-Lwun Ho, et al.
Plos One
|
April 5, 2013
The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma
Ling-Qun Kong, Xiao-Dong Zhu, Hua-Xiang Xu, et al.
Page
of 47
Search research articles
Search
Showing results (351-360 of 469) with videos related to
Sort By:
Page
of 47
Oncoimmunology
|
September 22, 2017
Colony-stimulating factor-1-induced AIF1 expression in tumor-associated macrophages enhances the progression of hepatocellular carcinoma
Hao Cai, Xiao-Dong Zhu, Jian-Yang Ao, et al.
Cell Death & Disease
|
May 1, 2018
The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target
Cheng-Dong Qin, De-Ning Ma, Shi-Zhe Zhang, et al.
Journal of Cancer Research and Clinical Oncology
|
May 22, 2010
Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expression
Yu-Quan Xiong, Hui-Chuan Sun, Xiao-Dong Zhu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 3, 2020
TRPC1/4/5 channels contribute to morphine-induced analgesic tolerance and hyperalgesia by enhancing spinal synaptic potentiation and structural plasticity
Wen-Guang Chu, Fu-Dong Wang, Zhi-Chuan Sun, et al.
Neural Regeneration Research
|
August 12, 2021
Downregulation of miR-491-5p promotes neovascularization after traumatic brain injury
Wei Tang, Zong-Duo Guo, Wei-Na Chai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
July 15, 2022
Hazard rate for postoperative recurrence in patients with hepatocellular carcinoma at Barcelona Clinic Liver Cancer stage 0 or A1: A multicenter observational study
Yan-Jun Xiang, Kang Wang, Hong-Ming Yu, et al.
Biomarker Research
|
January 13, 2025
The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapy
Tian He, Bin Xu, Lu-Na Wang, et al.
Cancer
|
September 2, 2006
P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma
Yong-Bing Qian, Ju-Bo Zhang, Wei-Zhong Wu, et al.
Clinical Chemistry
|
September 20, 2008
Abnormal matrix remodeling in adolescents and young adults with Kawasaki disease late after onset
Ming-Tai Lin, Shyh-Jye Chen, Yi-Lwun Ho, et al.
Plos One
|
April 5, 2013
The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma
Ling-Qun Kong, Xiao-Dong Zhu, Hua-Xiang Xu, et al.
Page
of 47